Haber DA - Search Results

1

A recurrent mutation in PALB2 in Finnish cancer families.

Erkko H, Xia B, Nikkilä J, Schleutker J, Syrjäkoski K, Mannermaa A, Kallioniemi A, Pylkäs K, Karppinen SM, Rapakko K, Miron A, Sheng Q, Li G, Mattila H, Bell DW, Haber DA, Grip M, Reiman M, Jukkola-Vuorinen A, Mustonen A, Kere J, Aaltonen LA, Kosma VM, Kataja V, Soini Y, Drapkin RI, Livingston DM, Winqvist R. Erkko H, et al. Among authors: haber da. Nature. 2007 Mar 15;446(7133):316-9. doi: 10.1038/nature05609. Epub 2007 Feb 7. Nature. 2007. PMID: 17287723

2

Selective loss of heterozygosity in multiple breast cancers from a carrier of mutations in both BRCA1 and BRCA2.

Bell DW, Erban J, Sgroi DC, Haber DA. Bell DW, et al. Among authors: haber da. Cancer Res. 2002 May 15;62(10):2741-3. Cancer Res. 2002. PMID: 12019146

3

Gefitinib-sensitizing EGFR mutations in lung cancer activate anti-apoptotic pathways.

Sordella R, Bell DW, Haber DA, Settleman J. Sordella R, et al. Among authors: haber da. Science. 2004 Aug 20;305(5687):1163-7. doi: 10.1126/science.1101637. Epub 2004 Jul 29. Science. 2004. PMID: 15284455

4

Pulmonary adenocarcinomas with mutant epidermal growth factor receptors.

Riemenschneider MJ, Bell DW, Haber DA, Louis DN. Riemenschneider MJ, et al. Among authors: haber da. N Engl J Med. 2005 Apr 21;352(16):1724-5. doi: 10.1056/NEJM200504213521622. N Engl J Med. 2005. PMID: 15843680 No abstract available.

5

Infrequent mutations of Archipelago (hAGO, hCDC4, Fbw7) in primary ovarian cancer.

Kwak EL, Moberg KH, Wahrer DC, Quinn JE, Gilmore PM, Graham CA, Hariharan IK, Harkin DP, Haber DA, Bell DW. Kwak EL, et al. Among authors: haber da. Gynecol Oncol. 2005 Jul;98(1):124-8. doi: 10.1016/j.ygyno.2005.04.007. Gynecol Oncol. 2005. PMID: 15913747

6

Inherited susceptibility to lung cancer may be associated with the T790M drug resistance mutation in EGFR.

Bell DW, Gore I, Okimoto RA, Godin-Heymann N, Sordella R, Mulloy R, Sharma SV, Brannigan BW, Mohapatra G, Settleman J, Haber DA. Bell DW, et al. Among authors: haber da. Nat Genet. 2005 Dec;37(12):1315-6. doi: 10.1038/ng1671. Epub 2005 Oct 30. Nat Genet. 2005. PMID: 16258541

7

A blood-based test for epidermal growth factor receptor mutations in lung cancer.

Bell DW, Haber DA. Bell DW, et al. Among authors: haber da. Clin Cancer Res. 2006 Jul 1;12(13):3875-7. doi: 10.1158/1078-0432.CCR-06-0670. Clin Cancer Res. 2006. PMID: 16818680 Review. No abstract available.

8

Epidermal growth factor receptor mutation testing in the care of lung cancer patients.

Sequist LV, Joshi VA, Jänne PA, Bell DW, Fidias P, Lindeman NI, Louis DN, Lee JC, Mark EJ, Longtine J, Verlander P, Kucherlapati R, Meyerson M, Haber DA, Johnson BE, Lynch TJ. Sequist LV, et al. Among authors: haber da. Clin Cancer Res. 2006 Jul 15;12(14 Pt 2):4403s-4408s. doi: 10.1158/1078-0432.CCR-06-0099. Clin Cancer Res. 2006. PMID: 16857818 Review.

9

An X chromosome gene, WTX, is commonly inactivated in Wilms tumor.

Rivera MN, Kim WJ, Wells J, Driscoll DR, Brannigan BW, Han M, Kim JC, Feinberg AP, Gerald WL, Vargas SO, Chin L, Iafrate AJ, Bell DW, Haber DA. Rivera MN, et al. Among authors: haber da. Science. 2007 Feb 2;315(5812):642-5. doi: 10.1126/science.1137509. Epub 2007 Jan 4. Science. 2007. PMID: 17204608

10

Molecular predictors of response to epidermal growth factor receptor antagonists in non-small-cell lung cancer.

Sequist LV, Bell DW, Lynch TJ, Haber DA. Sequist LV, et al. Among authors: haber da. J Clin Oncol. 2007 Feb 10;25(5):587-95. doi: 10.1200/JCO.2006.07.3585. J Clin Oncol. 2007. PMID: 17290067 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

312 results

Search Page